Evidence map›Paper›PMID 23568825›Full record

ArticleMagnetic resonance in medicine2014

Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking.

Dorit Granot, Michael K Nkansah, Margaret F Bennewitz, Kevin S Tang, Eleni A Markakis, Erik M Shapiro

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. PLGA-Based Composites for Various Biomedical Applications.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Liver cell therapy: is this the end of the beginning?Cellular and molecular life sciences : CMLS · 2018
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dorit GranotMolecular and Cellular MRI Laboratory, Magnetic Resonance Research Center, Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Michael K Nkansah
Margaret F Bennewitz
Kevin S Tang
Eleni A Markakis
Erik M Shapiro

Funding

NeurophysiologicP30NS052519 · NINDS · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED · 2007 to 2017
$6.7M
Single cell MRI of directed cell migration to strokeDP2OD004362 · OD · YALE UNIVERSITY · PI SHAPIRO, ERIK · 2008 to 2008
$2.5M
MRI-based immune cell tracking in Alzheimer?s diseaseR21AG041266 · NIA · YALE UNIVERSITY · PI SHAPIRO, ERIK · 2011 to 2012
$435k
Magnetic Resonance Imaging of NeurogenesisR21NS065297 · NINDS · YALE UNIVERSITY · PI SHAPIRO, ERIK · 2009 to 2010
$396k
NIA NIH HHS R21 AG041266NIH HHS DP2 OD004362NINDS NIH HHS P30 NS052519NINDS NIH HHS R21 NS065297
6 · The paper itself

Abstract

purposeTo design, fabricate, characterize, and in vivo assay clinically viable magnetic particles for MRI-based cell tracking.

methodsPoly(lactide-co-glycolide) (PLGA) encapsulated magnetic nano and microparticles were fabricated. Multiple biologically relevant experiments were performed to assess cell viability, cellular performance, and stem cell differentiation. In vivo MRI experiments were performed to separately test cell transplantation and cell migration paradigms, as well as in vivo biodegradation.

resultsHighly magnetic nano (∼100 nm) and microparticles (∼1-2 µm) were fabricated. Magnetic cell labeling in culture occurred rapidly achieving 3-50 pg Fe/cell at 3 h for different particles types, and >100 pg Fe/cell after 10 h, without the requirement of a transfection agent, and with no effect on cell viability. The capability of magnetically labeled mesenchymal or neural stem cells to differentiate down multiple lineages, or for magnetically labeled immune cells to release cytokines following stimulation, was uncompromised. An in vivo biodegradation study revealed that NPs degraded ∼80% over the course of 12 weeks. MRI detected as few as 10 magnetically labeled cells, transplanted into the brains of rats. Also, these particles enabled the in vivo monitoring of endogenous neural progenitor cell migration in rat brains over 2 weeks.

conclusionThe robust MRI properties and benign safety profile of these particles make them promising candidates for clinical translation for MRI-based cell tracking.

Indexed as

Magnetite NanoparticlesAnimalsCells, CulturedCell TrackingCoated Materials, BiocompatibleContrast MediaFemaleImage EnhancementLactic AcidMagnetic Resonance ImagingMiceNanocapsulesNeural Stem CellsParticle SizePolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerCoated Materials, BiocompatibleContrast MediaLactic AcidMagnetite NanoparticlesNanocapsulesPolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymer

Identifiers

PMID23568825
PMCPMC4336220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.